North Shore Equity Rotation ETF (KOOL)

NYSEARCA: KOOL · Real-Time Price · USD
13.34
0.00 (0.03%)
Mar 11, 2026, 4:00 PM EDT - Market closed
Assets$53.77M
Expense Ratio0.94%
PE Ratio32.24
Shares Out4.04M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume1,984
Open13.36
Previous Close13.34
Day's Range13.29 - 13.36
52-Week Low8.95
52-Week High13.62
Betan/a
Holdings42
Inception DateApr 1, 2024

About KOOL

Fund Home Page

The North Shore Equity Rotation ETF (KOOL) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, aiming to outperform the S&P 500 index by investing globally in stocks of any market capitalization. Investments are adjusted towards sectors the funds adviser identifies as possessing the greatest performance potential. KOOL was launched on Apr 1, 2024 and is issued by North Shore.

Asset Class Equity
Category Large Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol KOOL
ETF Provider North Shore

Top 10 Holdings

43.83% of assets
NameSymbolWeight
iShares Core S&P 500 ETFIVV7.10%
NVIDIA CorporationNVDA5.30%
Quanta Services, Inc.PWR4.44%
State Street Health Care Select Sector SPDR ETFXLV4.26%
Amazon.com, Inc.AMZN4.06%
iShares MSCI EAFE ETFEFA4.05%
Apple Inc.AAPL3.75%
Cameco CorporationCCJ3.63%
State Street Technology Select Sector SPDR ETFXLK3.62%
Kinder Morgan, Inc.KMI3.61%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 30, 2024$0.0228Dec 31, 2024
Sep 27, 2024$0.01385Sep 30, 2024
Jun 28, 2024$0.0245Jul 1, 2024

Performance

KOOL had a total return of 31.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.81%.

News

CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies

New York City, NY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- If you have been trying to lose weight but nothing seems to work anymore, you are not alone. Many people feel stuck. They eat better. They try to m...

20 days ago - GlobeNewsWire

The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss

AURORA, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Losing weight can often feel like an uphill battle, with conflicting advice and complicated diets making the process overwhelming. However, a simple y...

1 year ago - GlobeNewsWire

Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss

AURORA, Colo., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Ice Water Hack stands at the core of a rapidly rising weight-loss phenomenon that, according to Dr. Blaine—a leading advocate of metabolic research—rev...

1 year ago - GlobeNewsWire

ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Off...

2 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.

2 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update

Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools an...

2 years ago - PRNewsWire

ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento

An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell...

2 years ago - PRNewsWire

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...

2 years ago - PRNewsWire

Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript

Thermogenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - C...

2 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.

2 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and ...

2 years ago - PRNewsWire

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

RANCHO CORDOVA, Calif. , July 17, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...

2 years ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cau...

3 years ago - Seeking Alpha

ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.

3 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

Conference Call to be Held on May 15, 2023 RANCHO CORDOVA, Calif. , May 10, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and ser...

3 years ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) Q4 2022 Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff C...

3 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.

3 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update

Conference Call to be Held on March 30, 2023 RANCHO CORDOVA, Calif. , March 28, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point...

3 years ago - PRNewsWire

THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

RANCHO CORDOVA, Calif. , March 20, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...

3 years ago - PRNewsWire

THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

RANCHO CORDOVA, Calif. , March 16, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...

3 years ago - PRNewsWire

ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies

RANCHO CORDOVA, Calif. , March 15, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...

3 years ago - PRNewsWire

ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement

RANCHO CORDOVA, Calif. , Jan. 11, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...

3 years ago - PRNewsWire

ThermoGenesis Announces 1-for-45 Reverse Stock Split

RANCHO CORDOVA, Calif. , Dec. 21, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...

3 years ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q3 2022 Results - Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer...

3 years ago - Seeking Alpha

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2022 and Provide a Corporate Strategic Update

Conference  Call to be Held on November 10, 2022 RANCHO CORDOVA, Calif. , Nov. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and poi...

3 years ago - PRNewsWire

THERMOGENESIS CLOSES $2.05 MILLION PUBLIC OFFERING

RANCHO CORDOVA, Calif. , Oct. 28, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...

3 years ago - PRNewsWire

THERMOGENESIS PRICES $2.05 MILLION PUBLIC OFFERING

RANCHO CORDOVA, Calif. , Oct. 25, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...

3 years ago - PRNewsWire

ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

RANCHO CORDOVA, Calif. , Sept. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...

3 years ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q2 2022 Results - Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2022 Results Conference Call August 11, 2022 3:00 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer Je...

3 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update

Driven by Sales of the AXP, Total Revenues for the Quarter Rose 38% Compared to Prior Year Conference Call to be Held Today at 12:00 p.m. PT/3:00 p.m.

3 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update

Conference  Call to be Held on August 11, 2022 RANCHO CORDOVA, Calif. , Aug. 9, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and...

3 years ago - PRNewsWire

ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2022 Results - Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q1 2022 Earnings Conference Call May 19, 2022 4:30 AM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cau...

4 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.

4 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide a Corporate Strategic Update

Conference  Call to be Held on May 19, 2022 RANCHO CORDOVA, Calif. , May 18, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and se...

4 years ago - PRNewsWire

Thermogenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2021 Results - Earnings Call Transcript

Thermogenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update

Company Signs License Agreement With Boyalife Genomics and will Form TG Biosynthesis Division to Operate as CDMO for Cell and Cell-Based Gene Therapies Leases 35,475 SF To Be Built-Out as cGMP Complia...

4 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2021 and Provide a Corporate Strategic Update

Conference  Call to be Held on March 28, 2022 RANCHO CORDOVA, Calif. , March 23, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools an...

4 years ago - PRNewsWire

ThermoGenesis Holdings to Hold Reconvened Annual Meeting of Stockholders on January 13, 2022

RANCHO CORDOVA, Calif., Jan. 11, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), today announced that the Company's 2021 Annual Meeting of Stockholders (the "Annual Meeting") will re...

4 years ago - PRNewsWire

ThermoGenesis Holdings to Present at the H.C. Wainwright BioConnect Virtual Conference

RANCHO CORDOVA, Calif., Jan. 10, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, t...

4 years ago - PRNewsWire

ThermoGenesis Holdings Announces Adjournment of Annual Meeting of Stockholders

RANCHO CORDOVA, Calif., Dec. 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), announced that the Company's Annual Meeting of Stockholders (the "Annual Meeting") scheduled for Thur...

4 years ago - PRNewsWire

Recap: ThermoGenesis Holdings Q3 Earnings

ThermoGenesis Holdings (NASDAQ:THMO) reported its Q3 earnings results on Friday, November 12, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

4 years ago - Benzinga

Thermogenesis Holdings, Inc. (THMO) CEO Jeffery Cauble on Q3 2021 Results - Earnings Call Transcript

Thermogenesis Holdings, Inc. (THMO) CEO Jeffery Cauble on Q3 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2021, and Provides Corporate Update

RANCHO CORDOVA, Calif., Nov. 12, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, t...

4 years ago - PRNewsWire

ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update

RANCHO CORDOVA, Calif., Nov. 5, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, to...

4 years ago - PRNewsWire

ThermoGenesis Awarded NIH SBIR Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated manufacturing of Gene-engineered Autologous Cell (GEAC) Therapies

RANCHO CORDOVA, Calif., Sept. 14, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...

4 years ago - PRNewsWire

Thermogenesis Holdings to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

RANCHO CORDOVA, Calif., Sept. 7, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, to...

4 years ago - PRNewsWire

Thermogenesis Holdings, Inc. (THMO) on Q2 2021 Results - Earnings Call Transcript

Thermogenesis Holdings, Inc. (THMO) on Q2 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

Recap: ThermoGenesis Holdings Q2 Earnings

Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased 2.7% after the company reported Q2 results. Quarterly Results Earnings per share rose 62.75% over the past year to ($0.38), which missed the es...

4 years ago - Benzinga

Get unlimited news

Keep scrolling with Stock Analysis Pro